Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comparison of in vitro activities of gatifloxacin and ciprofloxacin against four taxa of rapidly growing mycobacteria.

Literature DB >> 12234861

Comparison of in vitro activities of gatifloxacin and ciprofloxacin against four taxa of rapidly growing mycobacteria.

Barbara A Brown-Elliott¹, Richard J Wallace, Christopher J Crist, Linda Mann, Rebecca W Wilson.

Abstract

By using current NCCLS broth microdilution methods, we found that gatifloxacin inhibited 90% of the isolates of the Mycobacterium fortuitum group at < or =0.12 micro g/ml and 90% of the Mycobacterium chelonae isolates at < or =4 micro g/ml. Gatifloxacin was generally fourfold more active than ciprofloxacin. We recommend that both gatifloxacin and ciprofloxacin be tested routinely against rapidly growing mycobacteria.

Entities: Chemical Species

Mesh：

Substances：

Year: 2002 PMID： 12234861 PMCID： PMC128789 DOI： 10.1128/AAC.46.10.3283-3285.2002

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

13 in total

1. Mycobacterium wolinskyi sp. nov. and Mycobacterium goodii sp. nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial Taxonomy.

Authors: B A Brown; B Springer; V A Steingrube; R W Wilson; G E Pfyffer; M J Garcia; M C Menendez; B Rodriguez-Salgado; K C Jost; S H Chiu; G O Onyi; E C Böttger; R J Wallace
Journal: Int J Syst Bacteriol Date: 1999-10

2. Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy.

Authors: R J Wallace; G Bedsole; G Sumter; C V Sanders; L C Steele; B A Brown; J Smith; D R Graham
Journal: Antimicrob Agents Chemother Date: 1990-01 Impact factor: 5.191

3. Successful treatment of disseminated Mycobacterium chelonae infection with linezolid.

Authors: B A Brown-Elliott; R J Wallace; R Blinkhorn; C J Crist; L B Mann
Journal: Clin Infect Dis Date: 2001-09-05 Impact factor: 9.079

4. Mycobacterium immunogenum sp. nov., a novel species related to Mycobacterium abscessus and associated with clinical disease, pseudo-outbreaks and contaminated metalworking fluids: an international cooperative study on mycobacterial taxonomy.

Authors: R W Wilson; V A Steingrube; E C Böttger; B Springer; B A Brown-Elliott; V Vincent; K C Jost; Y Zhang; M J Garcia; S H Chiu; G O Onyi; H Rossmoore; D R Nash; R J Wallace
Journal: Int J Syst Evol Microbiol Date: 2001-09 Impact factor: 2.747

5. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis.

Authors: A Telenti; F Marchesi; M Balz; F Bally; E C Böttger; T Bodmer
Journal: J Clin Microbiol Date: 1993-02 Impact factor: 5.948

6. Activities of linezolid against rapidly growing mycobacteria.

Authors: R J Wallace; B A Brown-Elliott; S C Ward; C J Crist; L B Mann; R W Wilson
Journal: Antimicrob Agents Chemother Date: 2001-03 Impact factor: 5.191

7. Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus.

Authors: R J Wallace; A Meier; B A Brown; Y Zhang; P Sander; G O Onyi; E C Böttger
Journal: Antimicrob Agents Chemother Date: 1996-07 Impact factor: 5.191

8. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin.

Authors: A Bauernfeind
Journal: J Antimicrob Chemother Date: 1997-11 Impact factor: 5.790

9. PCR amplification and restriction endonuclease analysis of a 65-kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria.

Authors: V A Steingrube; J L Gibson; B A Brown; Y Zhang; R W Wilson; M Rajagopalan; R J Wallace
Journal: J Clin Microbiol Date: 1995-01 Impact factor: 5.948

10. Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient.

Authors: P Tebas; F Sultan; R J Wallace; V Fraser
Journal: Clin Infect Dis Date: 1995-02 Impact factor: 9.079

8 in total

Review 1. Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors: Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal: Clin Microbiol Rev Date: 2012-07 Impact factor: 26.132

2. Comparison of Two Commercial Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) Systems for Identification of Nontuberculous Mycobacteria.

Authors: Barbara A Brown-Elliott; Thomas R Fritsche; Brooke J Olson; Sruthi Vasireddy; Ravikiran Vasireddy; Elena Iakhiaeva; Diana Alame; Richard J Wallace; John A Branda
Journal: Am J Clin Pathol Date: 2019-09-09 Impact factor: 2.493

3. In vitro activities of DC-159a, a novel fluoroquinolone, against Mycobacterium species.

Authors: Areeya Disratthakit; Norio Doi
Journal: Antimicrob Agents Chemother Date: 2010-04-05 Impact factor: 5.191

4. Polyphasic characterization reveals that the human pathogen Mycobacterium peregrinum type II belongs to the bovine pathogen species Mycobacterium senegalense.

Authors: Richard J Wallace; Barbara A Brown-Elliott; June Brown; Arnold G Steigerwalt; Leslie Hall; Gail Woods; Joann Cloud; Linda Mann; Rebecca Wilson; Christopher Crist; Kenneth C Jost; Dorothy E Byrer; Jane Tang; Jason Cooper; Elena Stamenova; Brian Campbell; Joyce Wolfe; Christine Turenne
Journal: J Clin Microbiol Date: 2005-12 Impact factor: 5.948

8. Comparison of In Vitro Susceptibility of Delafloxacin with Ciprofloxacin, Moxifloxacin, and Other Comparator Antimicrobials against Isolates of Nontuberculous Mycobacteria.

Authors: Barbara A Brown Elliott; Richard J Wallace
Journal: Antimicrob Agents Chemother Date: 2021-06-17 Impact factor: 5.191